2-[2-Benzoylamino-3-(2-fluoro-phenyl)-acryloylamino]-3-methyl-butyric acid

ID: ALA188414

Chembl Id: CHEMBL188414

PubChem CID: 5730271

Max Phase: Preclinical

Molecular Formula: C21H21FN2O4

Molecular Weight: 384.41

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C(NC(=O)/C(=C\c1ccccc1F)NC(=O)c1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C21H21FN2O4/c1-13(2)18(21(27)28)24-20(26)17(12-15-10-6-7-11-16(15)22)23-19(25)14-8-4-3-5-9-14/h3-13,18H,1-2H3,(H,23,25)(H,24,26)(H,27,28)/b17-12+

Standard InChI Key:  IGLVFZBSZQBERJ-SFQUDFHCSA-N

Associated Targets(Human)

ADAM12 Tchem ADAM12 (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM9 Tchem ADAM9 (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM10 Tchem ADAM10 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM17 Tchem ADAM17 (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.41Molecular Weight (Monoisotopic): 384.1485AlogP: 2.82#Rotatable Bonds: 7
Polar Surface Area: 95.50Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.68CX Basic pKa: CX LogP: 3.15CX LogD: -0.17
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -1.07

References

1. Oh M, Im I, Lee YJ, Kim YH, Yoon JH, Park HG, Higashiyama S, Kim YC, Park WJ..  (2004)  Structure-based virtual screening and biological evaluation of potent and selective ADAM12 inhibitors.,  14  (24): [PMID:15546732] [10.1016/j.bmcl.2004.09.082]

Source